Emilia Bulaevsky Zychlinsky
Geschäftsführer bei Exai Bio, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Patrick Arensdorf | M | - |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Elizabeth Ann Hutt Pollard | F | 57 | 9 Jahre | |
| Babak Alipanahi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Hani Goodarzi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Mike Pellini | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Shaun Rodriguez | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Seema Bhan | F | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Brian E. Ward | M | 71 | 4 Jahre | |
| Patrick Plewman | M | 58 | 1 Jahre | |
| Lori F. Rafield | M | 69 | 8 Jahre | |
| Christopher Lowe | M | 56 | - | |
| Alexander Johnson | M | - | 1 Jahre | |
| Sarah Schiltz | F | - | 4 Jahre | |
| John Curnutte | M | 72 | 1 Jahre | |
| Leone Patterson | F | 61 | 1 Jahre | |
| Andrew Galligan | M | 67 | 5 Jahre | |
| James Sulat | M | 73 | 1 Jahre | |
| David J. Foster | M | 66 | 1 Jahre | |
| Louis C. Bock | M | 59 | 1 Jahre | |
| Charles W. Patrick | M | 69 | 5 Jahre | |
| Adeoye Olukotun | M | 79 | 2 Jahre | |
| Paul Manners | M | - | - | |
| Jonathan Ruais | M | 47 | 1 Jahre | |
| William Harrison Hammond | M | - | 1 Jahre | |
| Mika Newton | M | - | - | |
| Robert Michael Richey | M | 71 | 3 Jahre | |
| Jean-Frédéric Viret | M | 58 | 2 Jahre | |
| E. Ralf Schoenbrunner | M | - | - | |
| Kenneth Charles Fang | M | 61 | - | |
| John Sperzel | M | 60 | - | |
| Robert J. Schott | M | - | - | |
| David W. Nikka | M | 69 | 2 Jahre | |
| Robert L. Wolfert | M | 70 | 1 Jahre | |
| Alexander Johnson | M | 50 | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 34 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Emilia Bulaevsky Zychlinsky
- Persönliches Netzwerk
